A Systematic Review of Psychological Distress that Occurs During the Treatment of Tuberculosis
DOI:
https://doi.org/10.61841/s2daq675Keywords:
Anxiety, Depression, Loneliness, Psychological Distress, TuberculosisAbstract
Compliance with treatment is the key to the success of the DOTS program in patients with tuberculosis. Psychological problems are one of the factors that can result in non-compliance of patients following the DOTS treatment regimen. The purpose of this review is to explain the psychological problems that can arise in tuberculosis patients following the treatment program. This study used a systematic review with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). A search used the following data sources: Scopus, Science Direct, Pubmed and ProQuest. The total articles found were 1042 articles, the articles used totaled 17. The article search was limited to the last 5 years (2015-2020), the English language as well as full-text articles. Keywords used were "Psychological Distress", "Emotional Distress", and "Tuberculosis". The population included were respondents aged> 18 years who were undergoing a tuberculosis treatment regimen and had no previous history of mental disorders. The results show that the psychological disorders that may arise during the treatment of tuberculosis patients are depression, anxiety, loneliness, and psychological distress. Psychological disorders that arise can be associated with a decrease in quality of life and risk of multidrug-resistance and non-compliance with treatment. Conclusion: psychological distress occurs among tuberculosis patients and the most experienced of these among patients is depression. Interventions in tackling psychological disorders in tuberculosis patients are urgently needed to help patients improve in terms of completing tuberculosis treatment. The role of health workers in providing comprehensive nursing care and support from families is very helpful for patients in overcoming their psychological problems.
Downloads
References
[1] World Health Organization, Global Tuberculosis Report 2017. 2017.
[2] A. C. Sweetland et al., “Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic,”
Int. J. Tuberc. Lung Dis., vol. 21, no. 8, pp. 852–861, 2017, doi: 10.5588/ijtld.16.0584.
[3] WHO World Health Organization, TUBERCULOSIS GLOBAL REPORT 2019. 2019.
[4] W. J. Katon, “Epidemiology and treatment of depression in patients with chronic medical illness,” Dialogues Clin. Neurosci., vol. 13, no. 1, pp. 7–24, 2011.
[5] A. Orovwigho, E. Olose, R. Uwakwe, D. Chukwujekwu, C. Aguocha, and M. Igwe, “Self Esteem and Psychological Distress among Patients with Tuberculosis and Fracture in Selected Hospitals in Enugu, Nigeria: A Comparative Study,” Int. Neuropsychiatr. Dis. J., vol. 7, no. 1, pp. 1–11, 2016, doi: 10.9734/indj/2016/24624.
[6] N. N. Hansel, A. W. Wu, B. Chang, and G. B. Diette, “Quality of life in tuberculosis: Patient and provider perspectives,” Qual. Life Res., vol. 13, no. 3, pp. 639–652, 2004, doi: 10.1023/B:QURE.0000021317.12945.f0.
[7] S. A. Dar, N. N. Shah, Z. A. Wani, and D. Nazir, “A prospective study on quality of life in patients with pulmonary tuberculosis at a tertiary care hospital in Kashmir, Northern India,” Indian J. Tuberc., vol. 66, no. 1, pp. 118–122, 2019, doi: 10.1016/j.ijtb.2018.07.002.
[8] T. Kastien-Hilka, B. Rosenkranz, M. Schwenkglenks, B. M. Bennett, and E. Sinanovic, “Association between health-related quality of life and medication adherence in pulmonary tuberculosis in South Africa,” Front. Pharmacol., vol. 8, no. DEC, 2017, doi: 10.3389/fphar.2017.00919.
[9] K. Peltzer, P. Naidoo, G. Matseke, J. Louw, G. Mchunu, and B. Tutshana, “Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa,” BMC Psychiatry, vol. 12, 2012, doi: 10.1186/1471-244X-12-89.
[10] J. Kehbila, C. J. Ekabe, L. N. Aminde, J. J. N. Noubiap, P. N. Fon, and G. L. Monekosso, “Prevalence and correlates of depressive symptoms in adult patients with pulmonary tuberculosis in the Southwest Region of Cameroon,” Infect. Dis. Poverty, vol. 5, no. 1, pp. 1–8, 2016, doi: 10.1186/s40249-016-0145-6.
[11] B. X. Paulo and B. Peixoto, “Emotional distress patients with several types of tuberculosis. A pilot study with patients from the Sanatorium Hospital of Huambo,” Int. J. Mycobacteriology, vol. 5, p. S58, 2016, doi: 10.1016/j.ijmyco.2016.11.002.
[12] R. Dantzer, J. C. O. Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, “From inflamation to sickness,”
Nat Rev Neurosci., vol. 9, no. 1, pp. 46–56, 2008, doi: 10.1038/nrn2297.From.
[13] K. T. Defined, “Systematic Reviews and Meta-Analyses,” no. February, pp. 57–59, 2011.
[14] T. T. Dasa et al., “Prevalence and associated factors of depression among tuberculosis patients in Eastern Ethiopia,” BMC Psychiatry, vol. 19, no. 1, pp. 1–8, 2019, doi: 10.1186/s12888-019-2042-6.
[15] R. N. Putri, “Perbandingan Sistem Kesehatan Negara Maju dan Negara Berkembang,” 2019.
[16] World Health Organization, National suicide prevention strategies, vol. 30. 2018.
[17] Gul E and E. Al, “Frequency of depression in patients suffering from Pulmonary Tuberculosis,” Pak J Chest Med, vol. 23, no. 1, pp. 03–07, 2017.
[18] T. T. Dasa et al., “Prevalence and associated factors of depression among tuberculosis patients in Eastern Ethiopia,” pp. 1–7, 2019.
[19] I. Mirza and R. Jenkins, “Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: Systematic review,” Br. Med. J., vol. 328, no. 7443, pp. 794–797, 2004, doi: 10.1136/bmj.328.7443.794.
[20] N. Rizvi, “Frequency of Depression and Anxiety among Tuberculosis Patients,” pp. 183–190, 2016, doi: 10.4236/jtr.2016.44021.
[21] B. Duko, A. Bedaso, G. Ayano, and Z. Yohannis, “Perceived Stigma and Associated Factors among Patient with Tuberculosis, Wolaita Sodo, Ethiopia: Cross-Sectional Study,” Tuberc. Res. Treat., vol. 2019, pp. 1–5, 2019, doi: 10.1155/2019/5917537.
[22] X. B. Wang et al., “A survey of anxiety and depressive symptoms in pulmonary tuberculosis patients with and without tracheobronchial tuberculosis,” Front. Psychiatry, vol. 9, no. JUL, pp. 1–10, 2018, doi: 10.3389/fpsyt.2018.00308.
[23] A. Molla, B. Mekuriaw, and H. Kerebih, “Depression and associated factors among patients with tuberculosis in Ethiopia: A cross-sectional study,” Neuropsychiatr. Dis. Treat., vol. 15, pp. 1887–1893, 2019, doi: 10.2147/NDT.S208361.
[24] R. E. Sulistyono, T. Susanto, and R. D. Tristiana, “Barriers in Tuberculosis Treatment in Rural Areas (Tengger, Osing and Pandalungan) in Indonesia Based on Public Health Center Professional Workers Perspectives: a Qualitative Research,” J. Ners, vol. 14, no. 1, pp. 62–68, 2019, doi: http://dx.doi.org/10.20473/jn.v14i1.10270.
[25] L. Qiu, Y. Tong, Z. Lu, Y. Gong, and X. Yin, “Depressive symptoms mediate the associations of stigma with medication adherence and quality of life in tuberculosis patients in China,” Am. J. Trop. Med. Hyg., vol. 100, no. 1, pp. 31–36, 2019, doi: 10.4269/ajtmh.18-0324.
[26] A. Yilmaz and O. Dedeli, “Assessment of anxiety, depression, loneliness and stigmatization in patients with tuberculosis,” ACTA Paul. Enferm., vol. 29, no. 5, pp. 549–557, 2016, doi: 10.1590/1982-0194201600076.
[27] B. Zhong, S. Chen, X. Tu, and Y. Conwell, “Loneliness and Cognitive Function in Older Adults : Findings From the Chinese Longitudinal Healthy Longevity Survey,” vol. 72, no. 1, pp. 120–128, 2017, doi: 10.1093/geronb/gbw037.
[28] J. S. Vogel, M. Swart, M. Slade, J. Bruins, M. van der Gaag, and S. Castelein, “Peer support and skills training
through an eating club for people with psychotic disorders: A feasibility study,” J. Behav. Ther. Exp. Psychiatry, vol. 64, no. February, pp. 80–86, 2019, doi: 10.1016/j.jbtep.2019.02.007.
[29] N. H. Long, E. Johansson, V. K. Diwan, and A. Winkvist, “Fear and social isolation as consequences of tuberculosis in Vietnam: A gender analysis,” Health Policy (New. York)., vol. 58, no. 1, pp. 69–81, 2001, doi: 10.1016/S0168-8510(01)00143-9.
[30] R. E. Sulistyono, T. Susanto, and R. D. Tristiana, “Patients Experience and Perception in Preventing Tuberculosis Transmission in Rural Areas: A Qualitative Research,” J. Keperawatan Padjadjaran, vol. 8, no. 1, 2020, doi: 10.24198/jkp.
[31] I. F. Walker et al., “Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study,” Int. J. Tuberc. Lung Dis., vol. 22, no. 7, 2018, doi: https://doi.org/10.5588/ijtld.17.0788.
[32] P. B. Xavier and B. Peixoto, “Emotional distress in angolan patients with several types of tuberculosis,” Afr. Health Sci., vol. 15, no. 2, pp. 378–384, 2015, doi: 10.4314/ahs.v15i2.10.
[33] S. P. L. Janardan Devkota, Narmada Devkota, “Health Related Quality of Life , Anxiety and Depression among Tuberculosis Patients in,” vol. 4, pp. 13–18, 2016.
[34] A. P. C. Dos Santos, T. K. Lazzari, and D. R. Silva, “Health-related quality of life, depression and anxiety in hospitalized patients with tuberculosis,” Tuberc. Respir. Dis. (Seoul)., vol. 80, no. 1, pp. 69–76, 2017, doi: 10.4046/trd.2017.80.1.69.
[35] H. H. Tola, M. Karimi, and M. S. Yekaninejad, “Effects of sociodemographic characteristics and patients’ health beliefs on tuberculosis treatment adherence in Ethiopia: A structural equation modelling approach,” Infect. Dis. Poverty, vol. 6, no. 1, pp. 1–10, 2017, doi: 10.1186/s40249-017-0380-5.
[36] I. K. Wijaya, . M., and R. Ummah, “The relationship of stress level and quality of life among patients with Tuberculosis in Makassar, Indonesia,” KnE Life Sci., vol. 2019, pp. 529–534, 2019, doi: 10.18502/kls.v4i13.5288.
[37] G. Theron et al., “Psychological distress and its relationship with non-adherence to TB treatment: A multicentre study,” BMC Infect. Dis., vol. 15, no. 1, 2015, doi: 10.1186/s12879-015-0964-2.
[38] H. H. Tola et al., “Psychological distress and its effect on tuberculosis treatment outcomes in Ethiopia,” Glob. Health Action, vol. 8, no. 1, 2015, doi: 10.3402/gha.v8.29019.
[39] R. D. Tristiana, R. Kumalasari, and M. Makhfudli, “Pengalaman Klien TB Paru yang Menjalani Pengobatan Fase Intensif di Puskesmas Taji Kabupaten Magetan,” Indones. J. Community Heal. Nurs., vol. 8, no. 1, 2019, doi: http://dx.doi.org/10.20473/ijchn.v8i1.12353.
[40] S. Gocer, O. Gunay, R. Ulutabanca, and Z. Sonkaya, “Factors affecting psychosocial adjustments to illness of active tuberculosis patients,” Med. Sci. | Int. Med. J., vol. 6, no. 4, p. 1, 2017, doi: 10.5455/medscience.2017.06.8644.
[41] K. Peltzer, P. Naidoo, G. Matseke, J. Louw, G. Mchunu, and B. Tutshana, “Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa,” 2012.
[42] G. S. De Araújo, S. M. Pereira, D. N. Dos Santos, J. M. Marinho, L. C. Rodrigues, and M. L. Barreto, “Common mental disorders associated with tuberculosis: A matched case-control study,” PLoS One, vol. 9, no. 6, 2014, doi: 10.1371/journal.pone.0099551.
[43] H. H. Tola et al., “The Effect of Psychosocial Factors and Patients’ Perception of Tuberculosis Treatment Non-Adherence in Addis Ababa, Ethiopia,” Ethiop J Heal. Sci, vol. 27, no. 5, pp. 447–458, 2017, doi: 10.4314/ejhs.v27i5.2.
[44] F. Ambaw, “Incidence of depression in people with newly diagnosed tuberculosis in Ethiopia : a cohort study,” 2020.
[45] T. M. Ayana, K. T. Roba, and M. O. Mabalhin, “Prevalence of psychological distress and associated factors among adult tuberculosis patients attending public health institutions in Dire Dawa and Harar cities, Eastern Ethiopia,” BMC Public Health, vol. 19, no. 1, pp. 1–9, 2019, doi: 10.1186/s12889-019-7684-2.
[46] K. M. De Castro-Silva et al., “Prevalence of depression among patients with presumptive pulmonary tuberculosis in Rio de Janeiro, Brazil,” Brazilian J. Psychiatry, vol. 41, no. 4, pp. 316–323, 2019, doi: 10.1590/1516-4446-2018-0076.
[47] K. Kumar, A. Kumar, P. Chandra, and H. Kansal, “A study of prevalence of depression and anxiety in patients suffering from tuberculosis,” J. Fam. Med. Prim. Care, vol. 5, no. 1, p. 150, 2016, doi: 10.4103/2249- 4863.184641.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
